Modulators of peripheral voltage-gated sodium channels for the treatment of neuropathic pain

Bibliography

• ORZA F, BOS WELL MV, ROSENBERG SK: Neuropathic pain: review of mechanisms and pharmacologic management. Neurorehabilitation. (2000) 14:15–23.
   PubMedGoogle Scholar
• HARDEN RN: Chronic neuropathic pain. Mechanisms, diagnosis, and treatment. Neurologist ( 2005) 11:111–122.
   Google Scholar
• ZIMMERMANN M: Pathobiology of neuropathic pain. Eur. j Pharmacol (2001) 429:23–37.
   PubMed Web of Science ®Google Scholar
• HANSSON P: Neuropathic pain: clinical characteristics and diagnostic workup. Eur. J. Pain ( 2002) 6(Suppl.A):47–50.
   Google Scholar
• JENSEN TS, GOTTRUP H, SINDRUP SH, BACH FW: The clinical picture of neuropathic pain. Eur. Pharmacol (2001) 429:1–11.
   PubMed Web of Science ®Google Scholar
• WOOLF CJ: Dissecting out mechanisms responsible for peripheral neuropathic pain: implications for diagnosis and therapy. Life Sci. (2004) 74:2605–2610.
   PubMed Web of Science ®Google Scholar
• GARBER K: Why it hurts: researchers seek mechanisms of cancer pain. J. Natl. Cancer Inst. (2003) 95:770–772.
   PubMedGoogle Scholar
• KOCOGLU H, PIRBUDAK L, PENCE S, BALAT 0: Cancer pain, pathophysiology, characteristics and syndromes. Eur. Gynaecol. Oncol (2002) 23:527–532.
   Google Scholar
• LUGER NM, MACH DB, SEVCIK MA, MANTYH PW: Bone cancer pain: from model to mechanism to therapy. J. Pain Symptom. Manage. (2005) 29:S32–S46.
   Google Scholar
• MANTYH PW: A mechanism-based understanding of bone cancer pain. Novartis. Found. Symp. (2004) 261:194–214.
   PubMedGoogle Scholar
• EISENBERG E, MCNICOL ED, CARR DB: Efficacy and safety of opioid agonists in the treatment of neuropathic pain of nonmalignant origin: systematic review and meta-analysis of randomized controlled trials. JAMA (2005) 293:3043–3052.
   PubMed Web of Science ®Google Scholar
• TRUJILLO KA: The neurobiology of opiate tolerance, dependence and sensitization: mechanisms of NMDA receptor-dependent synaptic plasticity. Neurotox. Res. (2002) 4:373–391.
   PubMed Web of Science ®Google Scholar
• BAILEY CP, CONNOR M: Opioids: cellular mechanisms of tolerance and physical dependence. Curr. Opin. Pharmacol (2005) 5:60–68.
   PubMed Web of Science ®Google Scholar
• TRANG T, QUIRION R, JHAMANDAS K: The spinal basis of opioid tolerance and physical dependence: involvement of calcitonin gene-related peptide, substance P, and arachidonic acid-derived metabolites. Peptides (2005) 26:1346–1355.
   PubMed Web of Science ®Google Scholar
• FRANTZ S: Vioxx risk could signify trouble in class. Nat. Rev. Drug Discov. (2004) 3:899–901.
   PubMedGoogle Scholar
• •Good review of the cardiac safety issues with COX-2 inhibitors.
   Google Scholar
• JUNI P, NARTEY L, REICHENBACH S et al.: Risk of cardiovascular events and rofecoxib: cumulative meta-analysis. Lancet (2004) 364:2021–2029.
   PubMed Web of Science ®Google Scholar
• HAINS BC, KLEIN JP, SAAB CY et aL: Upregulation of sodium channel Nav1.3 and functional involvement in neuronal hyperexcitability associated with central neuropathic pain after spinal cord injury. J. Neurosci. (2003) 23:8881–8892.
   Google Scholar
• WAXMAN SG: The molecular pathophysiology of pain: abnormal expression of sodium channel genes and its contributions to hyperexcitability of primary sensory neurons. Pain (1999) Supp1.6: 5133–5140.
   Google Scholar
• •Good general review of the involvement of Na„ channels in pain and neuronal hyperexcitability.
   Google Scholar
• JENSEN TS: Anticonvulsants in neuropathic pain: rationale and clinical evidence. Eur. J. Pain (2002) 6(Suppl.A): 61–68.
   Google Scholar
• •Good review of the rationale for the use of AEDs in chronic pain syndromes.
   Google Scholar
• REN K, DUBNER R: Central nervous system plasticity and persistent pain. Orofic. Pain (1999) 13:155–163.
   PubMedGoogle Scholar
• COLLINS SD, CHESSELL IP: Emerging therapies for neuropathic pain. Expert. Opin. Emerg-. Drugs (2005) 10:95–108.
   PubMedGoogle Scholar
• WIFFEN P, COLLINS S, MCQUAY H et al.: Anticonvulsant drugs for acute and chronic pain. Cochrane. Database. Syst. Rev. (2005) 3:1–18.
   Google Scholar
• PAPPAGALLO M: Newer antiepileptic drugs: possible uses in the treatment of neuropathic pain and migraine. Clin. Ther. (2003) 25:2506–2538.
   PubMed Web of Science ®Google Scholar
• DICKENSON AH, MATTHEWS EA, SUZUKI R: Neurobiology of neuropathic pain: mode of action of anticonvulsants. Eur J. Pain (2002) 6(Suppl A):51–60.
   Google Scholar
• HADJ TA: Pregabalin for peripheral neuropathic pain. Issues Emerg-. Health Technol (2005) 67:1–4.
   Google Scholar
• MELLEGERS MA, FURLAN AD, MAILIS k Gabapentin for neuropathic pain: systematic review of controlled and uncontrolled literature. Clin. J. Pain ( 2001) 17:284–295.
   PubMed Web of Science ®Google Scholar
• SURGES R, FEUERSTEIN TJ: Mode of action of gabapentin in chronic neuropathic pain syndromes. A short review about its cellular mechanisms in nociceptive neurotransmission. Arzneimittelfirschung (2002) 52:583–586.
   Google Scholar
• DWORKIN RH, KIRKPATRICK P: Pregabalin. Nat. Rev. Drug Discov. (2005) 4:455–456.
   PubMed Web of Science ®Google Scholar
• FIELD MJ, HUGHES J, SINGH L: Further evidence for the role of the a28 subunit of voltage dependent calcium channels in models of neuropathic pain. Br. J. PharmacoL (2000) 131:282–286.
   PubMed Web of Science ®Google Scholar
• MILJANICH GP: Ziconotide: neuronal calcium channel blocker for treating severe chronic pain. Cuff. Med. Chem. (2004) 11:3029–3040.
   PubMed Web of Science ®Google Scholar
• ••Good review of the ziconotide literaturejust prior to the drug's approval.
   Google Scholar
• GARBER K: Peptide leads new class of chronic pain drugs. Nat. BiotechnoL (2005) 23:399.
   PubMed Web of Science ®Google Scholar
• WINQUIST RJ, PAN JQ, GRIBKOFF VK: Use-dependent blockade of Cav2.2 voltage-gated calcium channels for neuropathic pain. Biochem. PharmacoL (2005) 70:489–499.
   Google Scholar
• •Good recent review of neuropathic pain and the importance of use-dependent mode of action for small molecule blockers of voltage-gated ion channels.
   Google Scholar
• LAI J, PORRECA F, HUNTER JC, GOLD MS: Voltage-gated sodium channels and hyperalgesia. Annu. Rev. PharmacoL Toxicol ( 2004) 44:371–397.
   PubMed Web of Science ®Google Scholar
• •Excellent recent review on Na„ channels and pain.
   Google Scholar
• PRIESTLEY T: Voltage-gated sodium channels and pain. Curr. Drug Targets CNS NeuroL Disord. (2004) 3:441–456.
   PubMedGoogle Scholar
• WAXMAN SG, CUMMINS TR, DIB-HAJJ SD, BLACK JA: Voltage-gated sodium channels and the molecular pathogenesis of pain: a review. J. Rehabil. Res. Dev. (2000) 37:517–528.
   PubMed Web of Science ®Google Scholar
• ARGOFF CE: New analgesics for neuropathic pain: the lidocaine patch. Clin. J. Pain (2000) 16:S62–S66.
   PubMed Web of Science ®Google Scholar
• TANELIAN DL, BROSE WG: Neuropathic pain can be relieved by drugs that are use-dependent sodium channel blockers: lidocaine, carbamazepine, and mexiletine. Anesthesiology (1991) 74:949–951.
   PubMedGoogle Scholar
• LOPREATO GF, LU Y, SOUTHWELL A et al.: Evolution and divergence of sodium channel genes in vertebrates. Proc. Natl. Acad. ScL USA (2001) 98:7588–7592.
   PubMedGoogle Scholar
• OGATAN, OHISHI Y: Molecular diversityof structure and function of the voltage-gated Na* channels. Jpn. j Pharmacol (2002) 88:365–377.
   PubMedGoogle Scholar
• YU FH, WESTENBROEK RE, SILOS-SANTIAGO I et aL: Sodium channel 134, a new disulfide-linked auxiliary subunit with similarity to 132.1 Neurosci. (2003) 23:7577–7585.
   Google Scholar
• CAI"IERALL WA, GOLDIN AL, WAXMAN SG: International Union of Pharmacology. )(XXIX. Compendium of voltage-gated ion channels: sodium channels. Pharmacol Rev. (2003) 55:575–578.
   Google Scholar
• ••The best source for brief summaries andacceptable nomenclature for the Na„ family of ion channels.
   Google Scholar
• QU Y, CURTIS R, LAWSON D et al.: Differential modulation of sodium channel gating and persistent sodium currents by the pp 132, and flo subunits. Mol Cell Neurosci. (2001) 18:570–580.
   PubMedGoogle Scholar
• YU FH, CATTERALL WA: Overview of the voltage-gated sodium channel family. Genome Biol (2003) 4:207.1–207.7
   Google Scholar
• KUHN FJ, GREEFF NG: Gating properties of a sodium channel with three arginines substituted by histidines in the central part of voltage sensor 54D4. Membr. Biol. ( 2003) 193:23–34.
   PubMedGoogle Scholar
• KONTIS KJ, ROUNAGHI A, GOLDIN AL: Sodium channel activation gating is affected by substitutions of voltage sensor positive charges in all four domains. J. Gen. Physiol. (1997) 110:391–401.
   PubMedGoogle Scholar
• CHANDA B, BEZANILLA F: Tracking voltage-dependent conformational changes in skeletal muscle sodium channel during activation. J. Gen. Physiol. (2002) 120:629–645.
   PubMed Web of Science ®Google Scholar
• KEYNES RD, ELINDER F: Modelling the activation, opening, inactivation and reopening of the voltage-gated sodium channel. Proc. Biol Sci. (1998) 265:263–270.
   PubMedGoogle Scholar
• CAMPBELL JN: Nerve lesions and the generation of pain. Muscle Nerve (2001) 24:1261–1273.
   PubMed Web of Science ®Google Scholar
• YAKSH TL: Pain after injury: some basic mechanisms. J. Fla. Med. Assoc. (1997) 84:16–19.
   PubMedGoogle Scholar
• DIB-HAJJ SD, FJELL J, CUMMINS TR et aL: Plasticity of sodium channel expression in DRG neurons in the chronic constriction injury model of neuropathic pain. Pain (1999) 83:591–600.
   PubMed Web of Science ®Google Scholar
• FJELL J, CUMMINS TR, FRIED K, BLACK JA, WAXMAN SG: In vivo NGF deprivation reduces SNS expression and TTX-R sodium currents in 1B4-negative DRG neurons. J. Neurophysiol (1999) 81:803–810.
   PubMed Web of Science ®Google Scholar
• RUSH AM, CRANER MJ, KAGEYAMAT et al.: Contactin regulates the current density and axonal expression of tetrodotoxin-resistant but not tetrodotoxin-sensitive sodium channels in DRG neurons. Eur. J. Neurosci. (2005) 22:39–49.
   PubMedGoogle Scholar
• ABDULLA FA, SMITH PA: Changes in Na* channel currents of rat dorsal root ganglion neurons following axotomy and axotomy-induced autotomy. j Neurophysiol (2002) 88:2518–2529.
   PubMed Web of Science ®Google Scholar
• RABERT DK, KOCH BD, ILNICKA M et al.: A tetrodotoxin-resistant voltage-gated sodium channel from human dorsal root ganglia, hPN3/SCN10A. Pain (1998) 78:107–114.
   PubMedGoogle Scholar
• SANGAMESWARAN L, FISH LM, KOCH BD et al.: A novel tetrodotoxin-sensitive, voltage-gated sodium channel expressed in rat and human dorsal root ganglia. J. Biol. Chem. (1997) 272:14805–14809.
   PubMed Web of Science ®Google Scholar
• TANAKA M, CUMMINS TR, ISHIKAWA K et al.: SNS Na* channel expression increases in dorsal root ganglion neurons in the carrageenan inflammatory pain model. Neuroreport (1998) 9:967–972.
   PubMed Web of Science ®Google Scholar
• HONG S, MORROW TJ, PAULSON PE, ISOM LL, WILEY JW: Early painful diabetic neuropathy is associated with differential changes in tetrodotoxin-sensitive and -resistant sodium channels in dorsal root ganglion neurons in the rat. J. Biol. Chem. (2004) 279:29341–29350.
   PubMed Web of Science ®Google Scholar
• RUSH AM, DIB-HAJJ SD, WAXMAN SG: Electrophysiological properties of two axonal sodium channels, Nav1.2 and Nav1.6, expressed in mouse spinal sensory neurones. J. Physiol (2005) 564:803–815.
   Google Scholar
• COTE PD, DE RY, COUPLAND SG et al.: Physiological maturation of photoreceptors depends on the voltage-gated sodium channel Nav1.6 (Scn8a). Neurosci . (2005) 25:5046–5050.
   Google Scholar
• TZOUMAKA E, TISCHLER AC, SANGAMESWARAN Let al.: Differential distribution of the tetrodotoxin-sensitive rPN4/NaCh6/Scn8a sodium channel in the nervous system. J. Neurosci. Res. (2000) 60:37–44.
   Google Scholar
• KRZEMIEN DM, SCHALLER KL, LEVINSON SR, CALDWELL JH: Immunolocalization of sodium channel isoform NaCh6 in the nervous system. J. Comp. NeuroL (2000) 420:70–83.
   PubMed Web of Science ®Google Scholar
• SCHALLER KL, CALDWELL JH: Developmental and regional expression of sodium channel isoform NaCh6 in the rat central nervous system. J. Comp. NeuroL (2000) 420:84–97.
   PubMedGoogle Scholar
• REESE KA, CALDWELL JH: Immunocytochemical localization of NaCh6 in cultured spinal cord astrocytes. Glia (1999) 26:92–96.
   PubMedGoogle Scholar
• SCHALLER KL, KRZEMIEN DM, YAROWSKY PJ, KRUEGER BK, CALDWELL JH: A novel, abundant sodium channel expressed in neurons and glia. J. Neurosci. (1995) 15:3231–3242.
   PubMed Web of Science ®Google Scholar
• DIETRICH PS, MCGIVERN JG, DELGADO SG et al.: Functional analysis of a voltage-gated sodium channel and its splice variant from rat dorsal root ganglia. Neurochem . (1998) 70:2262–2272.
   PubMed Web of Science ®Google Scholar
• KOHRMAN DC, SMITH MR, GOLDIN AL, HARRIS J, MEISLER MH: A missense mutation in the sodium channel Scn8a is responsible for cerebellar ataxia in the mouse mutant jolting. J. Neurosci. (1996) 16:5993–5999.
   PubMedGoogle Scholar
• RAMAN IM, SPRUNGER LK, MEISLER MH, BEAN BP: Altered subthreshold sodium currents and disrupted firing patterns in Purkinje neurons of Scn8a mutant mice. Neuron (1997) 19:881–891.
   PubMed Web of Science ®Google Scholar
• NASSAR MA, STIRLING LC, FORLANI G et al.: Nociceptor-specific gene deletion reveals a major role for Nav1.7 (PN1) in acute and inflammatory pain. Proc. Natl Acad. Sci. USA (2004) 101:12706–12711.
   Google Scholar
• TOLEDO-ARAL JJ, MOSS BL, HE ZJ et al.: Identification of PN1, a predominant voltage-dependent sodium channel expressed principally in peripheral neurons. Proc. Natl Acad. Sci. USA (1997) 94:1527–1532.
   PubMed Web of Science ®Google Scholar
• YEOMANS DC, LEVINSON SR, PETERS MC et al.: Decrease in inflammatory hyperalgesia by herpes vector-mediated knockdown of Nav1.7 sodium channels in primary afferents. Hum. Gene Ther. (2005) 16:271–277.
   Google Scholar
• CUMMINS TR, DIB-HAJJ SD, WAXMAN SG: Electrophysiological properties of mutant Na.„1.7 sodium channels in a painful inherited neuropathy. Neurosci . (2004) 24:8232–8236.
   Google Scholar
• DIB-HAJJ SD, RUSH AM, CUMMINS TR et al.: Gain-of-function mutation in Na.„1.7 in familial erythromelalgia induces bursting of sensory neurons. Brain (2005) 128:1847–1854.
   Google Scholar
• AKOPIAN AN, SOUSLOVA V, ENGLAND S et al.: The tetrodotoxin-resistant sodium channel SNS has a specialized function in pain pathways. Nat. Neurosci. (1999) 2:541–548.
   PubMed Web of Science ®Google Scholar
• SOUSLOVA VA, FOX M, WOOD JN, AKOPIAN AN: Cloning and characterization of a mouse sensory neuron tetrodotoxin-resistant voltage-gated sodium channel gene, Scn10a. Genomks (1997) 41:201–209.
   PubMedGoogle Scholar
• SANGAMESWARAN L, DELGADO SG, FISH LM et al.: Structure and function of a novel voltage-gated, tetrodotoxin-resistant sodium channel specific to sensory neurons. J. Biol. Chem. (1996) 271:5953–5956.
   PubMed Web of Science ®Google Scholar
• AKOPIAN AN, SIVIL01,11 L, WOOD JN: A tetrodotoxin-resistant voltage-gated sodium channel expressed by sensory neurons. Nature (1996) 379:257–262.
   PubMed Web of Science ®Google Scholar
• LAIRD JM, SOUSLOVA V, WOOD JN, CERVERO F: Deficits in visceral pain and referred hyperalgesia in Nav1.8 (SNS/PN3)-null mice. J. Neurosci. (2002) 22:8352–8356.
   PubMed Web of Science ®Google Scholar
• ROZA C, LAIRD JM, SOUSLOVA V, WOOD JN, CERVERO F: The tetrodotoxin-resistant Na* channel Nav1.8 is essential for the expression of spontaneous activity in damaged sensory axons of mice. J. PhysioL (2003) 550:921–926.
   Google Scholar
• LAI J, GOLD MS, KIM CS et ed.: Inhibition of neuropathic pain by decreased expression of the tetrodotoxin-resistant sodium channel, Nav1.8. Pain (2002) 95:143–152.
   Google Scholar
• WANG S, DAVIS BM, ZWICK M, WAXMAN SG, ALBERS KM: Reduced thermal sensitivity and Nav1.8 and TRPV1 channel expression in sensory neurons of aged mice. NeurobioL Aging (2005) Epub ahead of print.
   Google Scholar
• COWARD K, PLUMPTON C, FACER P et al.: Immunolocalization of SNS/PN3 and NaN/5N52 sodium channels in human pain states. Pain (2000) 85:41–50.
   PubMed Web of Science ®Google Scholar
• KRETSCHMER T, HAPPEL LT, ENGLAND JD et al.: Accumulation of PN1 and PN3 sodium channels in painful human neuroma-evidence from immunocytochemistry. Acta Neurochir. (2002) 144:803–810.
   PubMed Web of Science ®Google Scholar
• PORRECA F, LAI J, BIAN D et al.: A comparison of the potential role of the tetrodotoxin-insensitive sodium channels, PN3/SNS and NaN/5N52, in rat models of chronic pain. Proc. Natl Acad. Sci. USA (1999) 96:7640–7644.
   PubMed Web of Science ®Google Scholar
• YIANGOU Y, BIRCH R, SANGAMESWARAN L, EGLEN R, ANAND P: SNS/PN3 and 5N52/NaN sodium channel-like immunoreactivity in human adult and neonate injured sensory nerves. FEBS Lett. (2000) 467:249–252.
   PubMedGoogle Scholar
• DIB-HAJJ SD, BLACK JA, CUMMINS TR, WAXMAN SG: NaN/Na„1.9: a sodium channel with unique properties. Trends Neurosci. (2002) 25:253–259.
   Google Scholar
• CUMMINS TR, DIB-HAJJ SD, BLACK JA et al.: A novel persistent tetrodotoxin-resistant sodium current in SNS-null and wild-type small primary sensory neurons. J. Neurosci. (1999) 19:RC43:1–6.
   Google Scholar
• DIB-HAJJ SD, TYRRELL L, ESCAYG A et al.: Coding sequence, genomic organization, and conserved chromosomal localization of the mouse gene Scn1 la encoding the sodium channel NaN. Genomics (1999) 59:309–318.
   PubMed Web of Science ®Google Scholar
• DELMASP, COSTE B: Na* channel Nav1.9: in search of a gating mechanism. Trends Neurosci. (2003) 26:55–57.
   Google Scholar
• •Good review of issues surrounding the expression of Na„1.9.
   Google Scholar
• LIANG J, BROCHU RM, COHEN CJ et al.: Discovery of potent and use-dependent sodium channel blockers for treatment of chronic pain. Bioorg. Med. Chem. Lett. (2005) 15:2943–2947.
   PubMed Web of Science ®Google Scholar
• WALLACE MS: Calcium and sodium channel antagonists for the treatment of pain. Clin. J. Pain (2000) 16:S80–S85.
   Google Scholar
• LIVETT BG, GAYLER KR, KHALIL Z: Drugs from the sea: conopeptides as potential therapeutics. Curr. Med. Chem. (2004) 11:1715–1723.
   PubMed Web of Science ®Google Scholar
• LI RA, TOMASELLI GF: Using the deadlymu-conotoxins as probes of voltage-gated sodium channels. Toxicon (2004) 44:117–122.
   PubMed Web of Science ®Google Scholar
• •Good review of µ-conotoxin blockers of Na„ channels.
   Google Scholar
• SAFO P, ROSENBAUM T, SHCHERBATKO A et al.: Distinction among neuronal subtypes of voltage-activated sodium channels by ji-conotoxin PIIIA. j Neurosci. ( 2000) 20:76–80.
   PubMedGoogle Scholar
• KEIZER DW, WEST PJ, LEE EF et al.: Structural basis for tetrodotoxin-resistant sodium channel binding by u-conotoxin SmIIIA. J. Biol. Chem. (2003) 278:46805–46813.
   PubMedGoogle Scholar
• BULAJ G, WEST PJ, GARRETT JE et al.: Novel conotoxins from Conus striatus and Conus kinoshitai selectively block TTX-resistant sodium channels. Biochemistry (2005) 44:7259–7265.
   PubMed Web of Science ®Google Scholar
• BOWERSOX SS, SINGH T, NADASDI L et al.: Cardiovascular effects of omega-conopeptides in conscious rats: mechanisms of action. J. Cardiovasc. PharmacoL (1992) 20:756–764.
   PubMed Web of Science ®Google Scholar
• ILYIN VI, HODGES DD, WHITTEMORE ER et al.: V102862 (Co 102862): a potent, broad-spectrum state-dependent blocker of mammalian voltage-gated sodium channels. Br. J. PharmacoL (2005) 144:801–812.
   PubMed Web of Science ®Google Scholar
• SHAO B, VICTORY S, ILYIN VI et aL: Phenoxyphenyl pyridines as novel state-dependent, high-potency sodium channel inhibitors./ Med. Chem. (2004) 47:4277–4285.
   PubMedGoogle Scholar
• YANG J, GHARAGOZLOO P, YAO J et al.: 3-(4-Phenoxyphenyl)pyrazoles: a novel class of sodium channel blockers. J. Med. Chem. (2004) 47:1547–1552.
   PubMed Web of Science ®Google Scholar
• KIM SH, CHUNG JM: An experimental model for peripheral neuropathy produced by segmental spinal nerve ligation in the rat. Pain (1992) 50:355–363.
   PubMed Web of Science ®Google Scholar